Evaluation of Cardiovascular Effects of Methylphenidate in Children with Attention-deficit Hyperactivity Disorder

Objective: In patients with attention-deficit hyperactivity disorder (ADHD), methylphenidate (MPH) treatment may lead to serious cardiac problems. Therefore, this study was undertaken to assess cardiac effects and electrocardiographic (ECG) changes regarding risks of ventricular arrhythmia occurring...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Journal of Behçet Uz Children's Hospital
المؤلفون الرئيسيون: Ayşe Şimşek, Elif Akin, Engin Gerçeker, Murat Anıl
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Izmir Dr. Behcet Uz Children’s Hospital 2022-10-01
الموضوعات:
الوصول للمادة أونلاين:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=behcetuz&un=BUCHD-33341
_version_ 1848651637363572736
author Ayşe Şimşek
Elif Akin
Engin Gerçeker
Murat Anıl
author_facet Ayşe Şimşek
Elif Akin
Engin Gerçeker
Murat Anıl
author_sort Ayşe Şimşek
collection DOAJ
container_title Journal of Behçet Uz Children's Hospital
description Objective: In patients with attention-deficit hyperactivity disorder (ADHD), methylphenidate (MPH) treatment may lead to serious cardiac problems. Therefore, this study was undertaken to assess cardiac effects and electrocardiographic (ECG) changes regarding risks of ventricular arrhythmia occurring after initiation of MPH treatment in ADHD patients. Method: Thirty patients (mean age: 8.9+-1.93 years) diagnosed with ADHD and 41 healthy subjects (mean age: 9.78+-3.07 years) were included in this study blood pressures, heart rates, and ECGs of the patients were evaluated before and third month of treatment. ECG parameters including QRS, QT, corrected QT interval (QTc), QTdispersion (QTdis), Tp-Te, Tp-Te dispersion, and Tp-Te/QTc ratio were also assessed. Results: Untreated patients with ADHD and healthy subjects had similar systolic blood pressures and heart rates, although ADHD patients had higher diastolic blood pressures. An increase in heart rates, systolic and diastolic blood pressures was observed in the patient group in third month of treatment. Prior to MPH treatment, patients with ADHD and control subjects were compared in terms of ECG parameters: QRS, QT, QTc, QTdis, Tp-Te, Tp-Te dispersion, Tp-Te/QTc ratio but without any intergroup difference. Following MPH treatment, QRS, QT, QTc, QTdis did not change in the patient group but significant increases were observed in Tp-Te, Tp-Te dispersions, Tp-Te/ QTc ratios. Conclusion: Use of the MPH in ADHD patients is associated with alterations in ECG parameters, heart rates, diastolic and systolic blood pressures. Assessment of ECG parameters such as Tp-Te, Tp-Te dispersions, Tp-Te/QTc ratios may prove more beneficial for evaluating the risk of ventricular arrythmia in pediatric patients with ADHD.
format Article
id doaj-e3947429457e4ee2bf5933d11301ee25
institution Directory of Open Access Journals
issn 2822-4469
language English
publishDate 2022-10-01
publisher Izmir Dr. Behcet Uz Children’s Hospital
record_format Article
spelling doaj-e3947429457e4ee2bf5933d11301ee252025-11-03T00:28:35ZengIzmir Dr. Behcet Uz Children’s HospitalJournal of Behçet Uz Children's Hospital2822-44692022-10-0112320521010.4274/buchd.galenos.2022.33341BUCHD-33341Evaluation of Cardiovascular Effects of Methylphenidate in Children with Attention-deficit Hyperactivity DisorderAyşe Şimşek0Elif Akin1Engin Gerçeker2Murat Anıl3İzmir Democracy University, Buca Seyfi Demirsoy Training and Research Hospital, Clinic of Pediatrics and Diseases, Division of Pediatric Cardiology, İzmir, Turkeyİzmir Democracy University, Buca Seyfi Demirsoy Training and Research Hospital, Clinic of Child and Adolescent Psychiatry, İzmir, Turkeyİzmir Democracy University, Buca Seyfi Demirsoy Training and Research Hospital, Clinic of Pediatrics and Diseases, Division of Pediatric Cardiology, İzmir, Turkeyİzmir Democracy University, Buca Seyfi Demirsoy Training and Research Hospital, Clinic of Pediatrics and Diseases, Division of Pediatric Emergency, İzmir, TurkeyObjective: In patients with attention-deficit hyperactivity disorder (ADHD), methylphenidate (MPH) treatment may lead to serious cardiac problems. Therefore, this study was undertaken to assess cardiac effects and electrocardiographic (ECG) changes regarding risks of ventricular arrhythmia occurring after initiation of MPH treatment in ADHD patients. Method: Thirty patients (mean age: 8.9+-1.93 years) diagnosed with ADHD and 41 healthy subjects (mean age: 9.78+-3.07 years) were included in this study blood pressures, heart rates, and ECGs of the patients were evaluated before and third month of treatment. ECG parameters including QRS, QT, corrected QT interval (QTc), QTdispersion (QTdis), Tp-Te, Tp-Te dispersion, and Tp-Te/QTc ratio were also assessed. Results: Untreated patients with ADHD and healthy subjects had similar systolic blood pressures and heart rates, although ADHD patients had higher diastolic blood pressures. An increase in heart rates, systolic and diastolic blood pressures was observed in the patient group in third month of treatment. Prior to MPH treatment, patients with ADHD and control subjects were compared in terms of ECG parameters: QRS, QT, QTc, QTdis, Tp-Te, Tp-Te dispersion, Tp-Te/QTc ratio but without any intergroup difference. Following MPH treatment, QRS, QT, QTc, QTdis did not change in the patient group but significant increases were observed in Tp-Te, Tp-Te dispersions, Tp-Te/ QTc ratios. Conclusion: Use of the MPH in ADHD patients is associated with alterations in ECG parameters, heart rates, diastolic and systolic blood pressures. Assessment of ECG parameters such as Tp-Te, Tp-Te dispersions, Tp-Te/QTc ratios may prove more beneficial for evaluating the risk of ventricular arrythmia in pediatric patients with ADHD.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=behcetuz&un=BUCHD-33341attention-deficit hyperactivity disorderelectrocardiographymethylphenidate
spellingShingle Ayşe Şimşek
Elif Akin
Engin Gerçeker
Murat Anıl
Evaluation of Cardiovascular Effects of Methylphenidate in Children with Attention-deficit Hyperactivity Disorder
attention-deficit hyperactivity disorder
electrocardiography
methylphenidate
title Evaluation of Cardiovascular Effects of Methylphenidate in Children with Attention-deficit Hyperactivity Disorder
title_full Evaluation of Cardiovascular Effects of Methylphenidate in Children with Attention-deficit Hyperactivity Disorder
title_fullStr Evaluation of Cardiovascular Effects of Methylphenidate in Children with Attention-deficit Hyperactivity Disorder
title_full_unstemmed Evaluation of Cardiovascular Effects of Methylphenidate in Children with Attention-deficit Hyperactivity Disorder
title_short Evaluation of Cardiovascular Effects of Methylphenidate in Children with Attention-deficit Hyperactivity Disorder
title_sort evaluation of cardiovascular effects of methylphenidate in children with attention deficit hyperactivity disorder
topic attention-deficit hyperactivity disorder
electrocardiography
methylphenidate
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=behcetuz&un=BUCHD-33341
work_keys_str_mv AT aysesimsek evaluationofcardiovasculareffectsofmethylphenidateinchildrenwithattentiondeficithyperactivitydisorder
AT elifakin evaluationofcardiovasculareffectsofmethylphenidateinchildrenwithattentiondeficithyperactivitydisorder
AT engingerceker evaluationofcardiovasculareffectsofmethylphenidateinchildrenwithattentiondeficithyperactivitydisorder
AT muratanıl evaluationofcardiovasculareffectsofmethylphenidateinchildrenwithattentiondeficithyperactivitydisorder